ArticleCureus2025
Comparison of Myocardial Viability by Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Myocardial Infarction: An Observational Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Romosozumab in older adults: real-world patterns in fracture liaison service cohort.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Coronary artery disease (CAD) is one of the major causes of morbidity and mortality worldwide. Following myocardial infarction (MI), patients may develop significant ventricular dysfunction, and many others may harbor a burden of residual coronary disease, for which viability assessment of the suspected myocardial territory may be needed. Thus, this study aimed to assess the viability of myocardium by cardiac magnetic resonance imaging (MRI) in patients with MI and compare it with wall motion abnormality in echocardiography. Methods An observational cross-sectional study was conducted at Shahid Gangalal National Heart Centre and Bir Hospital, Kathmandu, Nepal. A total of 90 patients with a history of MI who underwent cardiac MRI were enrolled from May 12, 2023, to May 11, 2024. Echocardiography was analyzed for wall motion abnormalities and left ventricular ejection fraction (LVEF), while cardiac MRI was analyzed for wall motion abnormalities, LVEF, and late gadolinium enhancement (LGE). Myocardial segments were divided into those with LGE ≤50% (viable) and those with LGE >50% (non-viable). Wall motion abnormality by echocardiography and LGE by cardiac MRI were assessed for each segment and compared. Results Out of a total of 1,530 myocardial segments in 90 patients, 431 segments showed LGE on cardiac MRI, out of which 38 segments had LGE ≤50%, and 393 segments had LGE >50%. Most of the myocardial segments with LGE on cardiac MRI were in the left anterior descending (LAD) artery territory. All 38 segments that showed LGE ≤50% showed hypokinesia on echocardiogram. None of these segments showed akinesia or dyskinesia on echocardiogram. The majority of the segments with LGE >50% showed akinesia on echocardiogram, followed by hypokinesia and dyskinesia. None of the segments with LGE >50% had normal wall motion. Conclusion Cardiac MRI is an accurate and reliable tool to assess cardiac volumes, function, and LGE, thus determining the extent and severity of infarcted myocardium. Wall motion abnormalities by echocardiography, based on their severity, can also help to predict which involved myocardium may be viable and thus benefit in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.